327 results on '"Sajdak, Stefan"'
Search Results
2. Why Does Your Uterus Become Malignant? The Impact of the Microbiome on Endometrial Carcinogenesis
3. Mitochondria-related oxidative stress contributes to ovarian cancer-promoting activity of mesothelial cells subjected to malignant ascites
4. Common Variants in One-Carbon Metabolism Genes (MTHFR, MTR, MTHFD1) and Depression in Gynecologic Cancers
5. Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer
6. Malignant ascites determine the transmesothelial invasion of ovarian cancer cells
7. The association of CCAT2 rs6983267 SNP with MYC expression and progression of uterine cervical cancer in the Polish population
8. External validation of the IOTA ADNEX model performed by two independent gynecologic centers
9. The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors
10. Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells
11. Correction: Pakuła et al. Deciphering the Molecular Mechanism of Spontaneous Senescence in Primary Epithelial Ovarian Cancer Cells. Cancers 2020, 12, 296
12. Increased 17ß-hydroxysteroid dehydrogenase type 1 levels in primary cervical cancer
13. Novel markers in the diagnostics of endometriomas: Urocortin, ghrelin, and leptin or leukocytes, fibrinogen, and CA-125?
14. Using a Modified Polysaccharide as a Hemostatic Agent Results in Less Reduction of the Ovarian Reserve after Laparoscopic Surgery of Ovarian Tumors—Prospective Study
15. Serum arylesterase and paraoxonase activities in patients with ovarian tumors
16. Increased risk of low infant birth weight in pregnant women with low PAPP-A values measured in the first trimester.
17. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells
18. Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors
19. Increased risk of low infant birth weight in pregnant women with low PAPP-A values measured in the first trimester
20. Differential Expression of HIF1A, EPAS1, and VEGF Genes in Benign and Malignant Ovarian Neoplasia
21. A Unique Glassy Cell Carcinoma (GCC) of the Cervix Diagnosed during Pregnancy—A Case Report
22. Anti-ovarian antibodies in sera of patients with ovarian tumors
23. Replication Study for the Association of Seven Genome- Gwas-Identified Loci With Susceptibility to Ovarian Cancer in the Polish Population
24. Identification of New Molecular Biomarkers in Ovarian Cancer Using the Gene Expression Profile
25. A Rare Case of HELLP Syndrome with Hematomas of Spleen and Liver, Eclampsia, Severe Hypertension and Prolonged Coagulopathy—A Case Report
26. Progressing Vulvar Melanoma Caused by Instability in cKIT Juxtamembrane Domain: A Case Report and Review of Literature
27. Ciąże trojacze i o wyższej krotności
28. Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer
29. An Analysis of Polymorphisms Within the Wnt Signaling Pathway in Relation to Ovarian Cancer Risk in a Polish Population
30. Ciąża wielopłodowa
31. Wytyczne leczenia i profilaktyki żylnej choroby zatorowo-zakrzepowej u chorych onkologicznych leczonych operacyjnie z uwzględnieniem chorych poniżej 18. roku życia
32. Using a Modified Polysaccharide as a Hemostatic Agent Results in Less Reduction of the Ovarian Reserve after Laparoscopic Surgery of Ovarian Tumors—Prospective Study.
33. Usefulness of the HE4 biomarker as a second-line test in the assessment of suspicious ovarian tumors
34. DNMT1, DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population
35. Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish population
36. Altered Expression of ESR1, ESR2, PELP1 and c-SRC Genes Is Associated with Ovarian Cancer Manifestation
37. Role of osteopontin in differential diagnosis of ovarian tumors
38. Smoking and Smoking Cessation in the Risk for Fetal Growth Restriction and Low Birth Weight and Additive Effect of Maternal Obesity
39. The Influence of Maternal BMI on Adverse Pregnancy Outcomes in Older Women
40. Pre-Pregnancy Obesity vs. Other Risk Factors in Probability Models of Preeclampsia and Gestational Hypertension
41. Pre-Pregnancy Obesity, Excessive Gestational Weight Gain, and the Risk of Pregnancy-Induced Hypertension and Gestational Diabetes Mellitus
42. First Trimester Microelements and Their Relationships with Pregnancy Outcomes and Complications
43. Synchronous ovarian, endometrial and cervical cancer—case report
44. Deciphering the Molecular Mechanism of Spontaneous Senescence in Primary Epithelial Ovarian Cancer Cells
45. Performance of Selected Models for Predicting Malignancy in Ovarian Tumors in Relation to the Degree of Diagnostic Uncertainty by Subjective Assessment With Ultrasound
46. Ovarian steroid cell tumor as an example of severe hyperandrogenism in 45-year-old woman
47. First Trimester Serum Copper or Zinc Levels, and Risk of Pregnancy-Induced Hypertension
48. The Role of Early Pregnancy Maternal Selenium Levels on the Risk for Small-for-Gestational Age Newborns
49. The expression of Platelet-derived Growth factor receptors (PDGFRs) and their correlation with overall survival of patients with ovarian cancer
50. Can Serum Iron Concentrations in Early Healthy Pregnancy Be Risk Marker of Pregnancy-Induced Hypertension?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.